These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29761584)

  • 1. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo.
    Doeser MC; Schöler HR; Wu G
    Stem Cells; 2018 Aug; 36(8):1216-1225. PubMed ID: 29761584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient transcription factor (OSKM) expression is key towards clinical translation of
    de Lázaro I; Cossu G; Kostarelos K
    EMBO Mol Med; 2017 Jun; 9(6):733-736. PubMed ID: 28455313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences.
    Cieślar-Pobuda A; Knoflach V; Ringh MV; Stark J; Likus W; Siemianowicz K; Ghavami S; Hudecki A; Green JL; Łos MJ
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1359-1369. PubMed ID: 28460880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
    Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
    Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
    Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
    Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor reduces scar by inhibiting the differentiation of epidermal stem cells to myofibroblasts via the Notch1/Jagged1 pathway.
    Wang P; Shu B; Xu Y; Zhu J; Liu J; Zhou Z; Chen L; Zhao J; Liu X; Qi S; Xiong K; Xie J
    Stem Cell Res Ther; 2017 May; 8(1):114. PubMed ID: 28511663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Biodegradable Polymeric Microparticles Facilitate Scarless Wound Healing by Promoting Re-epithelialization and Inhibiting Fibrosis.
    Nosenko MA; Moysenovich AM; Zvartsev RV; Arkhipova AY; Zhdanova AS; Agapov II; Vasilieva TV; Bogush VG; Debabov VG; Nedospasov SA; Moisenovich MM; Drutskaya MS
    Front Immunol; 2018; 9():2851. PubMed ID: 30564244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
    Oh HR; Kim J; Kim J
    FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice.
    Huang S; Wu Y; Gao D; Fu X
    Cytotherapy; 2015 Jul; 17(7):922-31. PubMed ID: 25939802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases.
    Tamanini S; Comi GP; Corti S
    Mol Neurobiol; 2018 Aug; 55(8):6850-6862. PubMed ID: 29353456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
    Ocampo A; Reddy P; Martinez-Redondo P; Platero-Luengo A; Hatanaka F; Hishida T; Li M; Lam D; Kurita M; Beyret E; Araoka T; Vazquez-Ferrer E; Donoso D; Roman JL; Xu J; Rodriguez Esteban C; Nuñez G; Nuñez Delicado E; Campistol JM; Guillen I; Guillen P; Izpisua Belmonte JC
    Cell; 2016 Dec; 167(7):1719-1733.e12. PubMed ID: 27984723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanolayered siRNA delivery platforms for local silencing of CTGF reduce cutaneous scar contraction in third-degree burns.
    Castleberry SA; Golberg A; Sharkh MA; Khan S; Almquist BD; Austen WG; Yarmush ML; Hammond PT
    Biomaterials; 2016 Jul; 95():22-34. PubMed ID: 27108403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
    Parras A; Vílchez-Acosta A; Desdín-Micó G; Picó S; Mrabti C; Montenegro-Borbolla E; Maroun CY; Haghani A; Brooke R; Del Carmen Maza M; Rechsteiner C; Battiston F; Branchina C; Perez K; Horvath S; Bertelli C; Sempoux C; Ocampo A
    Nat Aging; 2023 Dec; 3(12):1509-1520. PubMed ID: 38012287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation.
    Lehmann M; Canatelli-Mallat M; Chiavellini P; Cónsole GM; Gallardo MD; Goya RG
    Curr Gene Ther; 2019; 19(4):248-254. PubMed ID: 31475896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human amniotic fluid stem cells have a unique potential to accelerate cutaneous wound healing with reduced fibrotic scarring like a fetus.
    Fukutake M; Ochiai D; Masuda H; Abe Y; Sato Y; Otani T; Sakai S; Aramaki-Hattori N; Shimoda M; Matsumoto T; Miyakoshi K; Kanai Y; Kishi K; Tanaka M
    Hum Cell; 2019 Jan; 32(1):51-63. PubMed ID: 30506493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous
    Kim J; Kim S; Lee SY; Jo BK; Oh JY; Kwon EJ; Kim KT; Adpaikar AA; Kim EJ; Jung HS; Kim HR; Roe JS; Hong CP; Kim JK; Koo BK; Cha HJ
    Sci Adv; 2023 Nov; 9(47):eadi8454. PubMed ID: 38000027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-145 in cardiac myofibroblast differentiation.
    Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
    J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin B
    Kovatcheva M; Melendez E; Chondronasiou D; Pietrocola F; Bernad R; Caballe A; Junza A; Capellades J; Holguín-Horcajo A; Prats N; Durand S; Rovira M; Yanes O; Stephan-Otto Attolini C; Kroemer G; Serrano M
    Nat Metab; 2023 Nov; 5(11):1911-1930. PubMed ID: 37973897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.